PubMed COVID-19 Clinical Care
1741 - 1750 of 1969 results found
mRNA COVID 19 vaccine-induced recall dermatitis after topical imiquimod
Description
No abstract
Mix and match COVID-19 vaccines: potential benefit and perspective from India
Description
No abstract
Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2
Description
The COVID-19 pandemic, caused by SARS-CoV-2, has led to over 750 million infections and 6.8 million deaths worldwide since late 2019. Due to the continuous evolution of SARS-CoV-2, many significant variants have emerged, creating ongoing challenges
Molecular test for COVID-19 diagnosis based on a colorimetric genomagnetic assay
Description
The world is in a long pandemic period caused by the SARS-CoV-2 virus and massive diagnostic tests to assist efforts to control the spread of the disease and also to avoid new coronavirus variants are still needed. Herein, we propose a simple and
Myocardial extracellular volume assessment at CT in hospitalized COVID-19 patients with regards to pulmonary embolism
Description
CONCLUSIONS: CT-derived ECV could help identify COVID-19 patients at higher risk of cardiac dysfunction, especially when related to PE, to potentially plan a dedicated, patient-tailored clinical approach.
MAM: Flexible Monte-Carlo Agent based Model for Modelling COVID-19 Spread
Description
In the three years since SARS-CoV-2 was first detected in China, hundreds of millions of people have been infected and millions have died. Along with the immediate need for treatment solutions, the COVID-19 epidemic has reinforced the need for
Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19
Description
Multisystem inflammatory disease in neonates (MIS-N) is a disease of immune dysregulation presenting in the newborn period. Thouvgh its etiopathogenesis is proposed to be similar to multisystem inflammatory disease in Children (MIS-C), the exact
Morbidity and mortality in hip surgery patients due to fracture during the COVID-19 pandemic
Description
CONCLUSION: 520 patients received surgical treatment for hip fracture during the first six months of the COVID-19 pandemic in 12 medical centers in Colombia. 21.10% suffered a complication during the early stage (30 days) and 4.77% during the midterm
